<DOC>
	<DOCNO>NCT00231322</DOCNO>
	<brief_summary>To assess influence seasonal variation Schistosoma haematobium transmission treatment outcome ( morbidity re-infection )</brief_summary>
	<brief_title>Influence Transmission Season Outcome Treatment Schistosoma Haematobium Infection Mozambique</brief_title>
	<detailed_description>General objective To provide knowledge influence transmission season ( high low ) outcome treatment assessed cure rate , re-infection rate , regression reappearance urinary tract morbidity rate treatment order optimise praziquantel treatment strategy morbidity control urinary schistosomiasis . Specific objective To determine prevalence intensity Schistosoma haematobium infection chemotherapy compare cure rate level re-infection chemotherapy administer high low transmission season . To assess urinary tract morbidity due Schistosoma haematobium ultrasonography compare regression reappearance urinary tract pathology chemotherapy administer high low transmission season . To correlate morbidity determine ultrasound infection morbidity parameter intensity infection , micro- macrohematuria , circulate cathodic antigen ( CCA ) urine , proteinuria leucocyturia determine sensitivity , specificity positive predictive value relation urinary tract morbidity . Study design The main research question concern influence transmission season treatment outcome address consecutive cohort study two separate comparable cohort . The first cohort examine treated praziquantel season high transmission , February/Mach ( group A ) second cohort examine treat low transmission season , July approximately 5 month later ( group B ) . Each cohort examine treatment 2 , 6 18 month treatment . The study carry 4 primary school ; two Machava J area two Costa Sol area . The school select base follow criterion : similar prevalence ( &gt; 50 % ) intensity S. haematobium infection ; absence low level S. mansoni infection ; minimum 2 class ( &gt; 35 pupil per class ) level ( 3rd 4th level ) similar distribution boy girls.Examinations include urine parasitology haematuria ultrasonography upper low urinary tract</detailed_description>
	<mesh_term>Hydronephrosis</mesh_term>
	<mesh_term>Hematuria</mesh_term>
	<mesh_term>Schistosomiasis haematobia</mesh_term>
	<mesh_term>Praziquantel</mesh_term>
	<criteria>child age 812 year All child present macrohaematuria severe pathology detect ultrasonography ( large mass , pseudopolyps hydronephrosis/hydroureter ) 6 month followup examination treat praziquantel exclude data analysis .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>Schistosoma haematobium</keyword>
	<keyword>haematuria</keyword>
	<keyword>ultrasonography</keyword>
	<keyword>Uganda</keyword>
	<keyword>Vesical polyp</keyword>
</DOC>